New patch pump aims to simplify diabetes management

NCT ID NCT07320495

Recruiting now Disease control Sponsor: Charles University, Czech Republic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new automated insulin delivery system for adults with type 1 diabetes. The system uses a patch pump and a smart algorithm to adjust insulin automatically. Researchers will check if it improves blood sugar control and is safe to use in daily life. 200 participants will be followed for 24 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Insulin pump TouchCare Nano A8 with the APGO system
What this could lead to: If successful, this could provide a more convenient and effective way for people with type 1 diabetes to manage their blood sugar automatically.
What could go wrong: This is an early real-world study without a control group, so results may not prove superiority over existing systems. Device malfunctions or user errors could still cause blood sugar swings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus type 1 diabetes mellitus 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 1

Contacts and locations

Locations

3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czechia
RECRUITING

Prague, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.